On September 26, 2023, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company's registered capital is CNY 91,970,802.92.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.81 CNY | -2.47% | -4.12% | -34.70% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.70% | 2.02B | |
+31.37% | 588B | |
-2.76% | 364B | |
+20.59% | 326B | |
+5.64% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.02% | 167B | |
+0.09% | 161B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd